18/12/2025 22:11
|
Medical, Health & Aged Care
BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer
FDA Fast Track Designation reflects the potential of BGB-B2033 in an area of high unmet...